Daniel Soo Lin Wong

Daniel Soo Lin Wong

Auto-generated profile, based on publicly available information

Daniel Soo Lin Wong

Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
BPBhav Harshad Parikh
Bhav Harshad Parikh
ZLZengping Liu
Zengping Liu
PBPaul Blakeley
Paul Blakeley
QLQianyu Lin
Qianyu Lin
MSMalay Singh
Malay Singh
XSXinyi Su
Xinyi Su
One common cause of vision loss after retinal detachment surgery is the formation of proliferative and contractile fibrocellular membranes. This aberrant wound healing process is mediated by epithelial-mesenchymal transition (EMT) and hyper-proliferation of retinal pigment epithelial (RPE) cells. Current treatment relies primarily on surgical removal of these membranes. Here, we demonstrate that a bio-functional polymer by itself is able to prevent retinal scarring in an experimental rabbit model of proliferative vitreoretinopathy. This is mediated primarily via clathrin-dependent internalisation of polymeric micelles, downstream suppression of canonical EMT transcription factors, reduction of RPE cell hyper-proliferation and migration. Nuclear factor erythroid 2–related factor 2 signalling pathway was identified in a genome-wide transcriptomic profiling as a key sensor and effector. This study highlights the potential of using synthetic bio-functional polymer to modulate RPE cellular behaviour and offers a potential therapy for retinal scarring prevention.

1 January 2022 in Biomaterials
Verified
Journal Article
Closed access
QLQianyu Lin
Qianyu Lin
ZLZengping Liu
Zengping Liu
DWDaniel S.L. Wong
Daniel S.L. Wong
CLChen Chuan Lim
Chen Chuan Lim
CLConnie K. Liu
Connie K. Liu
Xian Jun LohXian Jun Loh
Xian Jun Loh

17 October 2025 in Acta Biomaterialia
Verified
Journal Article
Open access
Hang LiuHang Liu
Hang Liu
DWDaniel Soo Lin Wong
Daniel Soo Lin Wong
BPBhav Parikh
Bhav Parikh
MHMing Hao
Ming Hao
QTQueenie Shu Woon Tan
Queenie Shu Woon Tan
ZLZengping Liu
Zengping Liu
Cell therapy is one of the most promising methods to treat retinal degenerative diseases, and crucial to its success is optimizing biomaterials to facilitate the delivery of retinal pigment epithelial (RPE) cells. This study explores the application of single-cell-pore-sized 3D printed polycaprolactone (PCL) scaffolds for cultivating human embryonic stem cell-derived RPE cell sheets. It compares them with track-etched polyethylene terephthalate (PET) membranes, the commercial products used in clinical trials for RPE cell delivery. We engineered two types of scaffolds at the microscale to optimize cell culture conditions, specifically focusing on pore size and fiber spacing. Protein expression analysis demonstrated that one scaffold with a pore size of ∼10 µm facilitated superior cellular integrity and function. Functional assessments, including barrier integrity, permeability, and phagocytosis assays, indicated that this scaffold enhanced nutrient exchange and maintained effective RPE functions akin to PET membranes. In an in vivo study, color fundus, optical coherence tomography, immunohistochemistry, and electroretinography revealed that 3D printed scaffolds exhibited biocompatibility, stability, and minimal inflammatory responses in the subretinal space of porcine models for 2 months and rabbit models for 14 months, with no adverse impact on retinal structure or function over either period. The findings suggest that 3D-printed biodegradable scaffolds present a viable alternative for RPE cell delivery, potentially advancing therapies for retinal degenerative conditions. STATEMENT OF SIGNIFICANCE: Cell therapy shows great promise for treating eye diseases that lead to vision loss. A crucial aspect of this therapy is delivering specialized retinal pigment epithelial (RPE) cells effectively. Our research presents a 3D-printed scaffold made from polycaprolactone (PCL), designed to carry RPE cells derived from human stem cells and dissolve after placement in the eye. We tested this scaffold in rabbits and pigs to evaluate its surgical handling, cell delivery effectiveness, and safety for human application. Our results refine implant design, paving the way for safer and more effective treatments for retinal diseases. Overall, this research enhances the application of cell therapy with scaffolds and offers valuable insights for future medical practices.

25 September 2025 in Biomaterials
Verified
Journal Article
Open access
ZLZengping Liu
Zengping Liu
DWDaniel Soo Lin Wong
Daniel Soo Lin Wong
BPBhav Parikh
Bhav Parikh
JLJian Li
Jian Li
AAAbdurrahmaan Al-Mubaarak
Abdurrahmaan Al-Mubaarak
XSXinyi Su
Xinyi Su
The retinal pigment epithelium (RPE) is essential for the health and function of the retina and, more specifically, the photoreceptors. Hence, the dysfunction of RPE leads to various retinal degeneration diseases. The rising prevalence of these disorders highlights the need for effective, large-scale cell-based therapies, particularly those utilizing stem cell-derived RPE cells. This study presents the development of a biodegradable, smooth surface microcarrier designed to facilitate the expansion and maturation of RPE cells derived from induced pluripotent stem cells (iPSCs). Using a three-dimensional (3D) culture system with polycaprolactone (PCL) porous microcarriers, we demonstrate that RPE cells exhibit comparable adhesion and growth on microcarriers as they do on traditional two-dimensional (2D) culture plates. The microcarrier system facilitates efficient maturation and yields higher quantities of functional RPE cells, highlighting its potential for large-scale production to meet both clinical demands and in vitro large-scale screening studies. Moreover, RPE cells cultured on this microcarrier can be directly frozen and recovered, maintaining their phenotypic and functional integrity upon thawing. This research showcases the scalability and practicality of RPE cell production, providing a robust solution for the storage and delivery of RPE cells. While our results establish the feasibility of direct cryopreservation and recovery of monolayer RPE cells on microcarriers, the designation of a 'ready-to-use' product format is preliminary and will require expanded assessment of long-term functionality, safety, and direct translational outcomes in future studies.

17 July 2026 in Biomaterials
Verified
Journal Article
Open access
WWWei Wu
Wei Wu
YCYujia Cao
Yujia Cao
QLQiyou Li
Qiyou Li
SHShuyun Hu
Shuyun Hu
DWDaniel Soo Lin Wong
Daniel Soo Lin Wong
ZLZengping Liu
Zengping Liu
Scaffold-based retinal pigment epithelium (RPE) transplantation is a candidate approach to preserve or recover vision for macular degeneration. Electrospun poly(ε-caprolactone) (PCL)/Gelatin (Gel) scaffolds have demonstrated support for cellular proliferation and function, yet their inadequate mechanical performance compromises surgical handling and deliverability. In this study, we incorporated low-oxidation graphene oxide (GO) into electrospun PCL/Gel scaffolds and evaluated their performance for human embryonic stem cell (hESC)-derived RPE cell transplantation. We found that the incorporation of low-oxidation GO improved scaffolds' WCA from 45.47 ± 8.44° to 27.48 ± 1.42° and tensile strength from 1.60 ± 0.06 MPa with an ultimate strain of 16% to 1.75 ± 0.07 MPa with an elongation at break of 44%, while maintaining fibrous formability and biocompatibility. The PCL/Gel/GO scaffolds supported RPE-specific protein expression (MITF, PAX6, CRALBP, ZO-1) and established favorable cell polarity, as indicated by apical Na+/K+-ATPase. Transmission electron microscopy assay also showed that the hESC-RPE cells on PCL/Gel/GO scaffolds formed apical microvilli. RNA-seq revealed the preservation of trophic factors and phagocytic function on PCL/Gel/GO scaffolds, which was further validated by augmented expression levels of CNTF, IGF1, and VEGFA, as well as improved fluorescent microsphere uptake capacity. Furthermore, the enhanced mechanical properties of the PCL/Gel/GO scaffold eliminated the need for additional treatment before implantation and facilitated surgical handling during implantation. In addition, the scaffold did not cause any observable short-term retinal dysfunction, indicating good short-term feasibility. Collectively, the scaffold structural features, RPE functional profiles, and surgical findings establish PCL/Gel/GO scaffolds as a versatile platform, warranting further investigation into their application in scaffold-based cell therapy for the treatment of macular degeneration.